Status:
COMPLETED
Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment
Lead Sponsor:
Tepecik Training and Research Hospital
Conditions:
Migraine
Headache Disorders, Primary
Eligibility:
All Genders
18-75 years
Brief Summary
Objective: Ultrasound-guided pulsed radiofrequency therapy can be used on the greateroccipital nerve (GON) in patients with chronic migraine (CM) who are unresponsive to conservative treatments. In th...
Detailed Description
Design and Study Population: The ethical approval of the current study was obtained from the Local Ethics Committee of Tepecik Education and Research Hospital. In this study, 25 patients who were dia...
Eligibility Criteria
Inclusion
- Chronic refractory migraine patients
Exclusion
- Other primer headache disorders, İntracranial lesion, Bleeding disorders.
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2021
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05199064
Start Date
September 15 2020
End Date
October 15 2021
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tepecik Training and Research Hospital
Izmir, Turkey (Türkiye), 35000